retatrutide parkinson's disease trial parkinson clinical retatrutide clinical trial Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson's disease: Cell-150cent Clinical Trials retatrutide parkinson's disease trial Time-to-event
Pay in 4 interest-free payments of $7.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17



























